In News

Follow this topic

Bookmark

Record learning outcomes

Nexium Control (esomeprazole) has switched to GSL.

Indicated for short-term management of reflux symptoms in adults aged 18 years or over, the OTC treatment is recommended for a maximum of 14 consecutive days. Pfizer says there are clear instructions in the PIL and on the packaging to help patients identify signs and symptoms for which they should seek advice from a healthcare professional.

Two pack sizes are available: 7s (£6.99) and 14s (£11.99). The launch campaign is being supported by a consumer website (nexiumcontrol.co.uk).

Pfizer: 0333 555 2526